Centiva Capital, LP Vertex Pharmaceuticals Inc Put Options Transaction History

Centiva Capital, LP

$5.63 Billion
Q2 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $2.98 Million - $3.26 Million	-7,300 Reduced 64.6%	4,000 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $2.16 Million - $2.59 Million	6,300 Added 126.0%	11,300 $4.6 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $1.69 Million - $1.81 Million	5,000 New	5,000 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $821,490 - $916,589	-3,000 Reduced 33.33%	6,000 $1.74 Million
Q2 2022 Aug 17, 2022	SELL	$234.96 - $292.55 $2.02 Million - $2.52 Million	-8,600 Reduced 48.86%	9,000 $2.54 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $2.79 Million - $3.29 Million	12,600 Added 252.0%	17,600 $4.59 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $885,050 - $1.12 Million	5,000 New	5,000 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2.72 Million - $3.04 Million	-15,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $2.01 Million - $2.37 Million	10,700 Added 248.84%	15,000 $3.02 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $2.05 Million - $2.69 Million	-9,100 Reduced 67.91%	4,300 $1.25 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $259,701 - $322,153	1,300 Added 10.74%	13,400 $3.19 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $66,684 - $89,564	-400 Reduced 3.2%	12,100 $2.65 Million
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $1.8 Million - $2.02 Million	10,800 Added 635.29%	12,500 $2.12 Million
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $1.56 Million - $1.81 Million	-9,500 Reduced 84.82%	1,700 $311,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $1.83 Million - $2.18 Million	11,200 New	11,200 $2.06 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account